BNP / NT-proBNP Blood Test

What Does This Test Measure?

BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal proBNP) are hormones released by heart muscle cells (cardiomyocytes) in response to stretching, specifically from increased pressure or volume overload. BNP and NT-proBNP are the primary biomarkers for diagnosing and monitoring heart failure.

Why Your Doctor Ordered This Test

BNP and NT-proBNP are ordered most commonly in the emergency department when a patient presents with acute shortness of breath; the doctor needs to rapidly distinguish whether the dyspnea is caused by heart failure, a lung problem like COPD or pneumonia, or both. The test is a cornerstone of the “rule-out” strategy: a very low level (BNP <100 pg/mL or NT-proBNP <300 pg/mL) makes heart failure highly unlikely, so the clinician can pivot to other causes. It is also checked in patients with suspected acute coronary syndromes, because a rise signals ventricular stress and helps stratify short-term risk. In the intensive care unit, BNP helps differentiate fluid overload from other causes of respiratory distress in septic or post-surgical patients.

Outside the emergency room, BNP/NT-proBNP is used serially to monitor chronic heart failure; tracking whether a patient’s condition is worsening or improving in response to diuretics, beta-blockers, or ACE inhibitors. A falling trend suggests successful treatment, while a rising level may indicate decompensation before symptoms appear. The test is also ordered to evaluate the cardiac burden of valvular heart disease (especially aortic stenosis and mitral regurgitation), to screen for cardiac involvement in systemic diseases like amyloidosis or hemochromatosis, and to assess perioperative risk before major non-cardiac surgery. In primary care, it may be used when a patient with risk factors such as hypertension, diabetes, or prior myocardial infarction develops new edema or fatigue, helping decide if echocardiography and referral are needed.

What High BNP / NT-proBNP Means

High BNP/NT-proBNP: heart failure; both with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF). Levels generally correlate with severity and are used to monitor treatment response (falling BNP = improving). Other causes: acute coronary syndrome (ischemic stretch), pulmonary embolism (right ventricular strain), atrial fibrillation, valvular heart disease, pulmonary hypertension, critical illness/sepsis, and chronic kidney disease (especially NT-proBNP; renally cleared; BNP is less affected). Obesity paradoxically lowers BNP/NT-proBNP; obese patients with heart failure may have " normal" levels.

What Low BNP / NT-proBNP Means

Low BNP/NT-proBNP: effectively rules out heart failure in the acute setting (high negative predictive value). In treated heart failure, low levels indicate good response to therapy and favorable prognosis. No disease state is associated with pathologically low BNP/NT-proBNP.

How to Prepare and What Affects the Result

Unlike many blood tests, BNP and NT-proBNP do not require fasting; you can eat and drink normally beforehand because food intake does not alter levels meaningfully. However, certain activities and medications can distort results. Strenuous physical exercise within a few hours before the draw may transiently elevate BNP due to increased ventricular wall stress, so patients are typically asked to rest for 15–30 minutes before the sample is taken. Timing of the test relative to medication doses matters: if you are taking sacubitril/valsartan (Entresto), which inhibits neprilysin, BNP levels will be artificially elevated, in this case NT-proBNP is the preferred marker because it is not affected by neprilysin inhibition. Recombinant BNP (nesiritide) infusion will also cause a false high BNP result. Biotin supplements in high doses (>5 mg/day) can interfere with immunoassays used in some labs; if possible, discontinue biotin for at least 48 hours before the test.

The sample must be handled correctly or the result may be unreliable. BNP is unstable in whole blood; it degrades quickly unless the specimen is collected in an EDTA (lavender-top) tube and the plasma is separated and refrigerated or frozen within 4 hours. NT-proBNP is far more stable; it can be collected in either serum or plasma (including gel barrier tubes) and can remain at room temperature for up to 72 hours without significant loss. For this reason, many laboratories now favor NT-proBNP, especially when samples are transported from outpatient clinics. In patients with severe renal impairment (eGFR <30 mL/min), NT-proBNP accumulates because it is cleared by the kidneys, so levels must be interpreted with caution using age- and kidney-adjusted cutoffs.

Common Misinterpretations

One of the most common misinterpretations is treating BNP and NT-proBNP as interchangeable numbers. Although both reflect the same biological process, their absolute values and clearance mechanisms differ markedly. NT-proBNP is renally excreted, so any degree of kidney dysfunction will elevate it independent of heart failure; a 75-year-old with an eGFR of 35 mL/min often has an NT-proBNP above 1,000 pg/mL without volume overload. Clinicians who apply the general “>300 = HF” rule without age- and kidney-adjusted cutoffs may incorrectly diagnose heart failure and prescribe diuretics unnecessarily. Conversely, obesity lowers circulating BNP and NT-proBNP because adipose tissue expresses clearance receptors; a patient with a BMI over 35 can have heart failure with a BNP level below 100 pg/mL and be falsely reassured. This “obesity paradox” leads to underdiagnosis of heart failure with preserved ejection fraction, which is common in overweight older women.

Another persistent error is assuming a normal BNP definitively rules out heart failure. While a low level has a negative predictive value above 95% in the acute setting, patients with early-stage, isolated right-heart failure, or constrictive pericarditis may still have serious cardiac compromise with BNP values in the gray zone or even normal range. High levels can also be misread as proof of heart failure when the true culprit is a massive pulmonary embolism; the right ventricular strain from a saddle embolus can push BNP above 500 pg/mL, leading a physician to focus on cardiac workup while delaying CT angiography. Similarly, sepsis and critical illness cause a systemic inflammatory response that releases BNP from myocytes, creating a false impression of primary cardiac disease. In heart failure monitoring, a drop in BNP after starting an ACE inhibitor may be mistaken for clinical improvement when the patient has actually received aggressive diuresis; the true picture requires correlating levels with symptoms, weight, and renal function.

Frequently Asked Questions

What does a high BNP level indicate?

A high BNP or NT-proBNP level usually signals that the heart’s ventricles are under increased stretch; most often from heart failure. In the emergency setting, BNP above 400 pg/mL or NT-proBNP above 1,800 pg/mL points strongly toward heart failure as the cause of shortness of breath. However, high levels also occur with kidney disease, pulmonary embolism, atrial fibrillation, critical illness, and advanced age. The degree of elevation often correlates with the severity of cardiac dysfunction, so very high values suggest more severe heart stress and a worse short-term prognosis.

What is the difference between BNP and NT-proBNP?

BNP is the biologically active hormone that promotes sodium and water excretion, while NT-proBNP is an inactive fragment released in equal amounts when proBNP is cleaved. They measure the same underlying cardiac stretch, but NT-proBNP has a longer half-life (about 120 minutes versus 20 minutes for BNP) and is cleared primarily by the kidneys, making it more influenced by renal function. BNP is less affected by kidney disease but is less stable in the blood sample and can be artificially elevated by the heart failure medication sacubitril/valsartan. Many labs now prefer NT-proBNP for its stability and wide dynamic range.

How do I prepare for a BNP blood test?

No fasting is needed; you can eat and drink as usual. Avoid strenuous exercise for 30 minutes before the draw because intense activity can transiently raise BNP. Tell your provider about medications, especially sacubitril/valsartan (Entresto) or nesiritide, as these elevate BNP. High-dose biotin supplements (>5 mg/day) should be stopped for 48 hours to prevent interference. The sample is collected from a vein, typically in an EDTA tube for BNP or a serum tube for NT-proBNP.

Can obesity affect BNP test results?

Yes, obesity significantly lowers BNP and NT-proBNP levels because fat cells have clearance receptors that remove natriuretic peptides from the bloodstream. A person with a body mass index above 35 can have clinically meaningful heart failure with a BNP level below the standard “normal” cutoff of 100 pg/mL. This can create a false sense of safety and delay diagnosis, particularly in heart failure with preserved ejection fraction, which is common in older overweight individuals. When interpreting BNP in obese patients, some experts suggest using roughly half the usual threshold to maintain sensitivity.

What can cause a false positive BNP test?

Several non-heart-failure conditions can raise BNP or NT-proBNP, mimicking cardiac disease. Kidney dysfunction is the top confounder: as eGFR falls below 30 mL/min, NT-proBNP can double or triple due to reduced clearance. Pulmonary embolism stretches the right ventricle, often pushing levels above 500 pg/mL. Sepsis, major burns, and critical illness release peptides from heart muscle cells. Atrial fibrillation and older age also elevate baseline values. Conversely, obesity masks high levels, causing false negatives. Always interpret the result alongside symptoms, renal function, and imaging.

Related Markers: Read Together for Full Context

BloodWorker reads lab values together, not in isolation. These related markers provide essential context for interpreting your BNP / NT-proBNP result: